PUBLISHER: The Business Research Company | PRODUCT CODE: 1760744
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760744
Wellness genomics involves utilizing an individual's genetic data to offer tailored guidance for enhancing health, nutrition, fitness, and overall well-being. Its objective is to improve lifestyle decisions and prevent illness by examining genetic tendencies beyond the scope of traditional medical genetics.
The primary types of wellness genomics include predictive testing, consumer genomics, and others. Predictive testing refers to a genetic assessment used to identify whether an individual without symptoms carries a gene variant that could lead to a future illness. This testing is applied in multiple contexts, such as direct-to-consumer (DTC) and professional settings, and serves numerous purposes including screening for breast and ovarian cancer, diabetes monitoring, colon cancer, Alzheimer's disease, prostate cancer, orthopedic and musculoskeletal conditions, among others.
The wellness genomics market research report is one of a series of new reports from The Business Research Company that provides wellness genomics market statistics, including wellness genomics industry global market size, regional shares, competitors with a wellness genomics market share, detailed wellness genomics market segments, market trends and opportunities, and any further data you may need to thrive in the wellness genomics industry. This wellness genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The wellness genomics market size has grown rapidly in recent years. It will grow from $4.99 billion in 2024 to $5.68 billion in 2025 at a compound annual growth rate (CAGR) of 13.8%. The growth during the historic period can be credited to the rising prevalence of chronic diseases, heightened consumer awareness about health, increased demand for personalized healthcare, a stronger emphasis on preventive healthcare, and the expansion of direct-to-consumer genomics.
The wellness genomics market size is expected to see rapid growth in the next few years. It will grow to $9.46 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to increasing affordability of testing, growing healthcare investments, increasing personalized nutrition interest, increasing disposable incomes, a growing geriatric population, and growing demand for personalized health and wellness. Major trends in the forecast period include advancements in sequencing tech, AI integration for insights, polygenic risk developments, DTC platform advancements, digital health integration, and tech partnerships acceleration.
The growing demand for personalized medicine is expected to drive the expansion of the wellness genomics market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and care based on an individual's specific genetic profile, lifestyle, and health conditions to achieve more accurate and effective outcomes. This demand is increasing as advancements in genetic technologies allow for more precise treatment plans tailored to an individual's unique genetic makeup, resulting in targeted and efficient therapies. Wellness genomics contributes to personalized medicine by offering genetic insights that guide personalized lifestyle and preventive health strategies based on individual biology. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that the FDA approved 16 new personalized therapies for rare disease patients in 2023, more than double the six approved in 2022. As a result, the rising demand for personalized medicine is boosting the growth of the wellness genomics market.
Leading companies in the wellness genomics sector are concentrating on the development of innovative solutions, such as personalized genomics platforms, to deliver customized health insights and lifestyle guidance based on genetic data. A personalized genomics platform refers to a service or technology that interprets an individual's genetic information to provide tailored health recommendations. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostics provider, introduced Geniee, a personalized genomics platform designed to generate individualized health insights using genetic analysis. Geniee delivers extensive genetic testing to help individuals understand how their genes affect responses to medications, nutrition, exercise, and diet. This information enables users to improve their health through customized wellness strategies, early risk identification, and better treatment options. The platform is designed to empower users to take charge of their health, representing a significant advancement in personalized medicine and preventive care.
In September 2023, InformedDNA, a US-based precision health firm, acquired gWell Health for an undisclosed sum. The acquisition is intended to merge gWell's personalized wellness technology with InformedDNA's expertise in clinical genetics, broadening the application of precision healthcare in areas such as oncology, drug metabolism, and maternity care. It also aims to make genomic-guided health decisions more widely accessible. gWell Health, a US-based digital wellness company, specializes in applying genomics to develop personalized wellness programs.
Major players in the wellness genomics market are Danaher Corporation, Eurofins Scientific SE, BGI Group, Agilent Technologies Inc., Bio-Rad Laboratories Inc., 23andMe Holding Co., Color Health Inc., Variantyx Inc., Segterra Inc., Dante Labs Inc., Pathway Genomics Corporation, NMC Healthcare LLC, Futura Genetics Ltd., Genopalate Inc., OhMyGene Inc., Rootine Labs Inc., Tania Flack Naturopath, Toolbox Genomics Inc., and Xcode Life Sciences Pvt. Ltd., GenepoweRx Healthcare Pvt. Ltd., Gx Sciences Inc., and Nebula Genomics Inc.
North America was the largest region in the wellness genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in wellness genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the wellness genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The wellness genomics market consists of revenues earned by entities providing services such as genetic testing, personalized nutrition analysis, fitness and wellness recommendations, disease risk assessment, ancestry and trait analysis, and preventive healthcare insights. The market value includes the value of related goods sold by the service provider or included within the service offering. The wellness genomics market also includes sales of genetic testing kits, bioinformatics software, personalized health reports, and nutrigenomics supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Wellness Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on wellness genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for wellness genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The wellness genomics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.